Cargando…

A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y

BACKGROUND: The study aimed to assess health-related quality of life (HRQoL) and to estimate the health utility of pediatric patients with hematological malignancies (HMs) in China. METHOD: A cross-sectional study recruited a series of pediatric inpatients diagnosed with HM from November 2018 to May...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yue, Zhou, Hui-Jun, Shen, Anle, Wu, Bin, Wang, Wei, Luo, Nan, Wang, Pei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874309/
https://www.ncbi.nlm.nih.gov/pubmed/36711389
http://dx.doi.org/10.3389/fpubh.2022.1050835
_version_ 1784877781491908608
author Sun, Yue
Zhou, Hui-Jun
Shen, Anle
Wu, Bin
Wang, Wei
Luo, Nan
Wang, Pei
author_facet Sun, Yue
Zhou, Hui-Jun
Shen, Anle
Wu, Bin
Wang, Wei
Luo, Nan
Wang, Pei
author_sort Sun, Yue
collection PubMed
description BACKGROUND: The study aimed to assess health-related quality of life (HRQoL) and to estimate the health utility of pediatric patients with hematological malignancies (HMs) in China. METHOD: A cross-sectional study recruited a series of pediatric inpatients diagnosed with HM from November 2018 to May 2019 in the Shanghai Children's Medical Center. Subjects were interviewed to collect sociodemographic information about themselves and their guardians. The EQ-5D-Y was completed by each patient to rate their own HRQoL, which later derived the health utility. The health status was also assessed by clinicians following the Eastern Cooperative Oncology Group (ECOG) system. Upon the descriptive analysis and univariate analysis, multivariate generalized linear models were built to explore the associations of risk factors with HRQoL measures of utility, Visual Analog Scale (VAS) score, and the five EQ-5D-Y domains. RESULTS: The 96 subjects had a mean age of 10.5 years and included 62 (64.4%) boys. There were 46 (47.9%) and 25 (26.0%) children diagnosed with acute lymphoblastic leukemia and non-Hodgkin's lymphoma, respectively. The means (SD) of utility and EQ-VAS scores were 0.88 (0.10) and 85.8 (15.1), respectively. Twenty-six (27.1%) patients were graded poor health by the ECOG standard (score 2/3). Both univariate and multivariate analyses found strong correlations between ECOG and HRQoL. After adjusting for covariates, poor ECOG score was significantly associated with an impaired utility and VAS of −0.103 and −8.65, respectively. With regard to individual HRQoL domains, worse ECOG was more likely to report health problems with an increased risk of 2.94 to 12.50; residence, income, guardians' education, and disease duration were also found to be significantly related to either the utility or certain health domains. CONCLUSION: The HRQoL of Chinese pediatric patients with HM is considered relatively poor and of great concern to healthcare. With the strong correlations between EQ-5D-Y-related HRQoL measures and the traditional clinical index ECOG, the EQ-5D-Y is able to provide valuable evidence for clinical decision-making at the individual level. At the same time, its health utility can inform resource allocation at a macro level.
format Online
Article
Text
id pubmed-9874309
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98743092023-01-26 A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y Sun, Yue Zhou, Hui-Jun Shen, Anle Wu, Bin Wang, Wei Luo, Nan Wang, Pei Front Public Health Public Health BACKGROUND: The study aimed to assess health-related quality of life (HRQoL) and to estimate the health utility of pediatric patients with hematological malignancies (HMs) in China. METHOD: A cross-sectional study recruited a series of pediatric inpatients diagnosed with HM from November 2018 to May 2019 in the Shanghai Children's Medical Center. Subjects were interviewed to collect sociodemographic information about themselves and their guardians. The EQ-5D-Y was completed by each patient to rate their own HRQoL, which later derived the health utility. The health status was also assessed by clinicians following the Eastern Cooperative Oncology Group (ECOG) system. Upon the descriptive analysis and univariate analysis, multivariate generalized linear models were built to explore the associations of risk factors with HRQoL measures of utility, Visual Analog Scale (VAS) score, and the five EQ-5D-Y domains. RESULTS: The 96 subjects had a mean age of 10.5 years and included 62 (64.4%) boys. There were 46 (47.9%) and 25 (26.0%) children diagnosed with acute lymphoblastic leukemia and non-Hodgkin's lymphoma, respectively. The means (SD) of utility and EQ-VAS scores were 0.88 (0.10) and 85.8 (15.1), respectively. Twenty-six (27.1%) patients were graded poor health by the ECOG standard (score 2/3). Both univariate and multivariate analyses found strong correlations between ECOG and HRQoL. After adjusting for covariates, poor ECOG score was significantly associated with an impaired utility and VAS of −0.103 and −8.65, respectively. With regard to individual HRQoL domains, worse ECOG was more likely to report health problems with an increased risk of 2.94 to 12.50; residence, income, guardians' education, and disease duration were also found to be significantly related to either the utility or certain health domains. CONCLUSION: The HRQoL of Chinese pediatric patients with HM is considered relatively poor and of great concern to healthcare. With the strong correlations between EQ-5D-Y-related HRQoL measures and the traditional clinical index ECOG, the EQ-5D-Y is able to provide valuable evidence for clinical decision-making at the individual level. At the same time, its health utility can inform resource allocation at a macro level. Frontiers Media S.A. 2023-01-11 /pmc/articles/PMC9874309/ /pubmed/36711389 http://dx.doi.org/10.3389/fpubh.2022.1050835 Text en Copyright © 2023 Sun, Zhou, Shen, Wu, Wang, Luo and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Sun, Yue
Zhou, Hui-Jun
Shen, Anle
Wu, Bin
Wang, Wei
Luo, Nan
Wang, Pei
A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y
title A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y
title_full A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y
title_fullStr A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y
title_full_unstemmed A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y
title_short A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y
title_sort cross-sectional study evaluating health-related quality of life of chinese pediatric patients with hematological malignancies using eq-5d-y
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874309/
https://www.ncbi.nlm.nih.gov/pubmed/36711389
http://dx.doi.org/10.3389/fpubh.2022.1050835
work_keys_str_mv AT sunyue acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT zhouhuijun acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT shenanle acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT wubin acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT wangwei acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT luonan acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT wangpei acrosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT sunyue crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT zhouhuijun crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT shenanle crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT wubin crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT wangwei crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT luonan crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy
AT wangpei crosssectionalstudyevaluatinghealthrelatedqualityoflifeofchinesepediatricpatientswithhematologicalmalignanciesusingeq5dy